Both in Biotechnology
enGene Therapeutics vs LENZ Therapeutics
Over the past year ENGN returned −73.7% and LENZ returned −87.7%; their daily moves had a correlation of 0.09.
ENGN −73.7% LENZ −87.7%Growth of $1, one year, split-adjusted
| Metric | ENGN | LENZ |
|---|---|---|
| Price | $1.72 | $3.46 |
| Market cap | $115.3M | $108.7M |
| Today | +6.17% | −1.14% |
| 1 month | −4.4% | −8.7% |
| 6 months | −80.6% | −64.3% |
| Year to date | −81.0% | −78.4% |
| 1 year | −75.1% | −87.6% |
| Revenue growth (YoY) | — | +9.7% |
| Gross margin | — | 94.9% |
| Net margin | — | −581.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.1× |
| Net cash | $241.0M | $220.0M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 75.9% |
| Short % of float | 3.4% | 46.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).